Medical Xpress news story
For decades, TB patients have been prescribed a multidrug regimen lasting approximately six months. This “one-size-fits-all” approach keeps most people tied to treatment longer than necessary. Yet it also ensures that a minority of patients susceptible to relapse will be cured.
In two studies — one involving an animal model and the other a cohort of 704 patients — scientists asked whether the standard TB treatment regimen lasting half a year could be streamlined by shaving off a couple of months.
Read the full news story here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #5, 15 February 2026).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Source : Medical Xpress
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.